This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rosetta Genomics Ltd (ROSG)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 7.93M 16.77M 30.80M 735.00K
Receivables 498.00K 434.00K 163.00K 309.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 7.65M 7.67M 301.00K 17.00K
Total Current Assets 16.45M 25.00M 31.75M 1.21M
Property, Plant & Equipment, Gross 3.15M 2.90M 2.26M 2.30M
Accumulated Depreciation & Depletion 2.33M 2.03M 1.72M 1.71M
Property, Plant & Equipment, Net 822.00K 874.00K 546.00K 592.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 4.00K 8.00K 231.00K 242.00K
Total Non-Current Assets 826.00K 882.00K 777.00K 834.00K
Liabilities & Shareholder Equity
Total Assets 17.28M 25.88M 32.53M 2.04M
Accounts Payable 563.00K 906.00K 754.00K 1.85M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 2.21M 1.94M 1.27M 1.85M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 2.00K 309.00K 364.00K 552.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.00K 309.00K 364.00K 552.00K
Total Liabilities 2.21M 2.25M 1.63M 2.40M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 15.06M 23.63M 30.90M -356.00K
Common Par 1.83M 1.61M 1.38M 108.00K
Additional Paid In Capital 136.16M 130.42M 125.02M 84.58M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -122.92M -108.40M -95.50M -85.04M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 15.06M 23.63M 30.90M -356.00K
Total Equity 15.06M 23.63M 30.90M -356.00K
Total Liabilities & Stock Equity 17.28M 25.88M 32.53M 2.04M
Total Common Shares Outstanding 11.76M 10.47M 9.10M 701.24K
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 3.26K 3.26K 3.26K 14.00
Basic Weighted Shares Outstanding 11.24M 9.59M 4.45M 507.62K
Diluted Weighted Shares Outstanding 11.24M 9.59M 4.45M 507.62K
Number of Employees 52 45 28 22
Number of Part-Time Employees 0 0 0 0
ROSG News

ROSG Rosetta Genomics Ltd

Analysts Ratings for ROSG

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 3 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ROSG ANALYST REPORT

Brokerage Partners

ROSG Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs